血管疾患治療機器市場：製品別（ステント、バルーン、カテーテル、プラーク改質装置、血行動態改善装置、その他）、エンドユーザー別（病院・心臓センター、外来外科センター）。世界の機会分析および産業予測、2021年--2030年

Vascular Disease Devices Market by Product (Stents, Balloons, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), and End User (Hospitals and Cardiac Centers, and Ambulatory Surgical Center): Global Opportunity Analysis and Industry Forecast, 2021––2030

世界の血管疾患治療機器市場は、2020年には265億2224万ドルとなり、2021年から2030年までのCAGRは6.50%を記録し、2030年には518億214万ドルに達すると予測されています。血管疾患とは、末梢動脈疾患（PAD）など... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年1月27日	US$6,168 シングルユーザーライセンスライセンス・価格情報・注文方法はこちら	220	英語

サマリー

世界の血管疾患治療機器市場は、2020年には265億2224万ドルとなり、2021年から2030年までのCAGRは6.50%を記録し、2030年には518億214万ドルに達すると予測されています。
血管疾患とは、末梢動脈疾患（PAD）など、自然の血液循環系に影響を及ぼすあらゆる病的状態を指します。血管疾患には、脳卒中、末梢動脈疾患（PAD）、腹部大動脈瘤（AAA）、頸動脈疾患（CAD）、動静脈奇形（AVM）、重症虚血肢（CLTI）、肺塞栓（血栓）、深部静脈血栓（DVT）、慢性静脈不全（CVI）および静脈瘤が含まれます。血管系疾患の発生率は、ここ数年で著しく増加しています。世界保健機関（WHO）によると、2019年に心血管疾患（CVD）で死亡した人は推定1790万人です。血管疾患は、高血圧、コレステロールの沈着、傷害、遺伝、感染症などが原因で引き起こされることがあります。糖尿病、高血圧、肥満、飲酒、タバコの喫煙は、血管疾患の危険因子とされています。
バルーン、ステント、カテーテル、フィルターなどの特殊な器具は、さまざまな血管手術を行うために使用されます。動脈ステントは、冠動脈の中で膨らむ小さな金属製の網目状の管です。ステントは、多くの場合、血管形成術の最中または直後に設置されます。動脈が再び閉塞するのを防ぐことができます。同様に、閉塞部ではバルーンが膨らみ、バネのようなステントが拡張して動脈内の所定の位置にロックされます。ステントは永久に動脈内に留まり、動脈を開いたままにして心臓への血流を改善します。さらに、心臓カテーテルは非常に小さく柔軟な中空のチューブで、鼠径部、腕、首などの血管に挿入されます。その後、外科医はカテーテルを血管を通して大動脈と心臓に通します。心臓カテーテル検査は、冠動脈疾患による胸の痛みやストレステストの異常、弁の漏れや狭窄などの心臓弁膜症、肺の高血圧状態、血栓など、心臓や血管の一般的な問題を診断・評価するために使用されます。
世界的な血管系疾患の増加により、血管系疾患治療機器市場の成長が見込まれています。例えば、米国心臓協会の報告書によると、2019年には1億9720万人が虚血性心疾患（IHD）と共に生活しています。また、糖尿病と高血圧の増加は、血管疾患デバイス市場の成長を促進します。2021年の世界保健機関（WHO）によると、世界で30～79歳の成人12億8000万人が高血圧症であると推定されています。高齢者は血管疾患にかかりやすい。したがって、老年人口の増加は、さらに血管疾患デバイス市場の成長に貢献しました。しかし、製品のリコールや不具合は市場の成長を制限する可能性があります。
血管疾患治療器市場は、製品、エンドユーザー、地域によって区分されます。製品別では、ステント、バルーン、カテーテル、プラーク修正デバイス、血行動態変化デバイス、その他に分類されます。さらに、ステントは冠動脈用ステント、末梢用ステント、ステント関連製品に分類されます。冠動脈ステントは、薬剤溶出型ステント、ベアメタル型ステント、生体吸収型ステントに分類されます。末梢ステントはさらに、腸骨、大腿-膝関節、腎臓、頸動脈に分類されます。ステント関連製品は、合成グラフトと大静脈フィルターに分類されます。
バルーンはさらに、ベア/ノーマルバルーン、ドラッグコーティングバルーン、スコアリングバルーンに分類されます。カテーテルは、血管造影、IVUS/OCT、ガイディングに分類されます。
エンドユーザー別では、病院・心臓センターと外来手術センターに分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAに分かれて分析されています。
本レポートで紹介する主要企業は、メドトロニック、ボストン・サイエンティフィック・コーポレーション、アボット・ラボラトリーズ、ベクトン・ディッキンソン＆カンパニー、テルモ、コルディス、B. Braun Melsungen Ag、Ivascular、メリットメディカル、コーニクリケ・フィリップス・エヌ・ブイなどです。

ステークホルダーにとっての主なメリット

本レポートでは、差し迫った投資ポケットを解明するために、世界の血管疾患用デバイスの市場規模を現在の動向と将来予測とともに詳細に分析しています。
2021年から2030年までの市場分析を提供しており、利害関係者が市場に存在する機会を活用することを可能にすると期待されます。
地域の包括的な分析は、地域市場を理解し、戦略的な事業計画を促進し、優勢な機会を決定するのに役立ちます。
主要企業のプロファイルと成長戦略は、世界の血管疾患デバイス市場成長の競争展望を理解するために徹底的に分析されています。

主要な市場セグメント
#製品別
## ステント
### 冠動脈ステント
#### 薬剤溶出性ステント
####ベアメタル冠動脈
####ステントバイオアブソーバーブルステント

###ペリフェラルステント
####腸骨
####大腿骨-膝窩部
####腎臓
####頚動脈

###ステント関連インプラント
####合成グラフト
####大静脈フィルター

##バルーン
###ベア/ノーマルバルーン
###薬剤コーティングバルーン
###スコアリングバルーン

##カテーテル
###血管造影
###IVUS/OCT
###ガイド

##プラーク修正装置
##血行力学的な流れを変える装置
##その他
#エンドユーザー別
##病院・心臓病センター
##外来手術センター

#地域別
##北アメリカ
###米国
###カナダ
###メキシコ

##ヨーロッパ
###ドイツ
###フランス
###イギリス
###イタリア
###スペイン
###その他のヨーロッパ

##アジア太平洋地域
###日本
###中国
###オーストラリア
###インド
###韓国
###その他のアジア太平洋地域

#ラメア
###ブラジル
###サウジアラビア
###南アフリカ
###LAMEAの残りの地域

主要な市場関係者
メドトロニック
ボストン・サイエンティフィック社
アボット・ラボラトリーズ
ベクトン・ディッキンソンアンドカンパニー
テルモ株式会社
コルディス
B. ブラウン・メルシュンゲン社
アイバスキュラー
メリットメディカル
フィリップスN.V.

ページTOPに戻る

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of cardiovascular diseases
3.5.1.2.Rise in number of diabetes and hypertension patients
3.5.1.3.The R&D in vascular disease

3.5.2.Restraint

3.5.2.1.Product recall and failure

3.5.3.Opportunity

3.5.3.1.Increase in aging population.

3.5.4.Impact analysis

3.6.Impact analysis of COVID-19 on the vascular disease devices market

CHAPTER 4:VASCULAR DISEASES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Stents

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis by country
4.2.4.Market size and forecast, by stents types

4.2.4.1.Coronary Stents
4.2.4.2.Peripheral Stents
4.2.4.3.Stent Related Implant

1.2Balloons

4.2.5.Key market trends, growth factors, and opportunities
4.2.6.Market size and forecast, by region
4.2.7.Market analysis by country

4.2.7.1.Bare/Normal balloons
4.2.7.2.Drug coated balloons
4.2.7.3.Scoring balloons

1.3Catheters

4.2.8.Key market trends, growth factors, and opportunities
4.2.9.Market size and forecast, by region

4.2.10.Market analysis by country

4.2.10.1.Angiography
4.2.10.2.IVUS/OCT
4.2.10.3.Guiding

1.4Plaque Modification Devices

4.2.11.Key market trends, growth factors, and opportunities

4.2.12.Market size and forecast, by region
4.2.13.Market analysis by country

1.5Hemodynamic Flow Alteration Devices

4.2.14.Key market trends, growth factors, and opportunities
4.2.15.Market size and forecast, by region
4.2.16.Market analysis by country

1.6Others

4.2.17.Key market trends, growth factors, and opportunities
4.2.18.Market size and forecast, by region
4.2.19.Market analysis by country

CHAPTER 5:VASCULAR DISEASE DEVICES MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals & cardiac centers

5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Ambulatory Surgical Center

5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

CHAPTER 6:VASCULAR DISEASE DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by country

6.2.2.1.U.S.

6.2.2.1.1.U.S. vascular disease devices market, by product
6.2.2.1.2.U.S. vascular disease devices market, by end user

6.2.2.2.Canada

6.2.2.2.1.Canada vascular disease devices market, by product
6.2.2.2.2.Canada vascular disease devices market, by end user

6.2.2.3.Mexico

6.2.2.3.1.Mexico vascular disease devices market, by product
6.2.2.3.2.Mexico vascular disease devices market, by end user

6.2.3.North America vascular disease devices market, by product
6.2.4.North America vascular disease devices market, by end user

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by country

6.3.2.1.Germany

6.3.2.1.1.Germany vascular disease devices market, by product
6.3.2.1.2.Germany vascular disease devices market, by end user

6.3.2.2.France

6.3.2.2.1.France vascular disease devices market, by product
6.3.2.2.2.France vascular disease devices market, by end user

6.3.2.3.UK

6.3.2.3.1.UK vascular disease devices market, by product
6.3.2.3.2.UK vascular disease devices market, by end user

6.3.2.4.Italy

6.3.2.4.1.Italy vascular disease devices market, by product
6.3.2.4.2.Italy vascular disease devices market, by end user

6.3.2.5.Spain

6.3.2.5.1.Spain vascular disease devices market, by product
6.3.2.5.2.Spain vascular disease devices market, by end user

6.3.2.6.Rest of Europe

6.3.2.6.1.Rest of Europe vascular disease devices market, by product
6.3.2.6.2.Rest of Europe vascular disease devices market, by end user

6.3.3.Europe vascular disease devices market, by product
6.3.4.Europe vascular disease devices market, by end user

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by country

6.4.2.1.China

6.4.2.1.1.China vascular disease devices market, by product
6.4.2.1.2.China vascular disease devices market, by end user

6.4.2.2.Japan

6.4.2.2.1.Japan vascular disease devices market, by product
6.4.2.2.2.Japan vascular disease devices market, by end user

6.4.2.3.India

6.4.2.3.1.India vascular disease devices market, by product
6.4.2.3.2.India vascular disease devices market, by end user

6.4.2.4.Australia

6.4.2.4.1.Australia vascular disease devices market, by product
6.4.2.4.2.Australia vascular disease devices market, by end user

6.4.2.5.South Korea

6.4.2.5.1.South Korea vascular disease devices market, by product
6.4.2.5.2.South Korea vascular disease devices market, by end user

6.4.2.6.Rest of Asia-Pacific

6.4.2.6.1.Rest of Asia-Pacific vascular disease devices market, by product
6.4.2.6.2.Rest of Asia-Pacific vascular disease devices market, by end user

6.4.3.Asia-Pacific vascular disease devices market, by product
6.4.4.Asia-Pacific vascular disease devices market, by end user

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities
6.5.2.Market size and forecast, by country

6.5.2.1.Brazil

6.5.2.1.1.Brazil vascular disease devices market, by product
6.5.2.1.2.Brazil vascular disease devices market, by end user

6.5.2.2.Saudi Arabia

6.5.2.2.1.Saudi Arabia vascular disease devices market, by product
6.5.2.2.2.Saudi Arabia vascular disease devices market, by end user

6.5.2.3.South Africa

6.5.2.3.1.South Africa vascular disease devices market, by product
6.5.2.3.2.South Africa vascular disease devices market, by end user

6.5.2.4.Rest of LAMEA

6.5.2.4.1.Rest of LAMEA vascular disease devices market, by product
6.5.2.4.2.Rest of LAMEA vascular disease devices market, by end user

6.5.3.LAMEA vascular disease devices market, by product
6.5.4.LAMEA vascular disease devices market, by end user

CHAPTER 7:COMPANY PROFILES

7.1.Koninklijke Philips N.V. (Philips)

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance

7.2.Medtronic Plc.

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segment
7.2.4.Product portfolio
7.2.5.Business performance

7.3.Abbott Laboratories.

7.3.1.Company overview
7.3.2.Operating business segment
7.3.3.Product portfolio
7.3.4.Business performance
7.3.5.Key strategic moves and developments

7.4.Boston scientific corporation.

7.4.1.Company overview
7.4.2.Operating business segment
7.4.3.Product portfolio
7.4.4.Business performance
7.4.5.Key strategic moves and developments

7.5.Becton Dickinson And Company.

7.5.1.Company overview
7.5.2.Operating business segment
7.5.3.Product portfolio
7.5.4.Business performance

7.6.Terumo Corporation.

7.6.1.Company overview
7.6.2.Operating business segment
7.6.3.Product portfolio
7.6.4.Business performance
7.6.5.Key strategic moves and developments

7.7.Cordis

7.7.1.Company overview
7.7.2.Operating business segment
7.7.3.Product portfolio
7.7.4.Business performance

7.8.B. BRAUN MELSUNGEN AG

7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performance

7.9.IVASCULAR

7.9.1.Company overview
7.9.2.Operating business segment
7.9.3.Product portfolio
7.9.4.Key strategic moves and developments

7.10.Merit Medical Systems, Inc.

7.10.1.Company overview
7.10.2.Operating business segment
7.10.3.Product portfolio
7.10.4.Business performance
7.10.5.Key strategic moves and developments

List of Tables

LIST OF TABLES

TABLE 01.VASCULAR DISEASES MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.VASCULAR DISEASE DEVICES MARKET FOR STENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 01.VASCULAR DISEASE DEVICES MARKET FOR STENTS, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.VASCULAR DISEASE DEVICES MARKET FOR BALLOONS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.VASCULAR DISEASE DEVICES MARKET FOR CATHETERS, BY REGION, 2020–2030 ($MILLION)
TABLE 04.VASCULAR DISEASE DEVICES MARKET FOR PLAQUE MODIFICATION DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 05.VASCULAR DISEASE DEVICES MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 06.VASCULAR DISEASE DEVICES MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 07.VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 08.VASCULAR DISEASE DEVICES MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 09.VASCULAR DISEASE DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 10.VASCULAR DISEASE DEVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 11.NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 12.U.S. VASCULAR DISEASE DEVICES MARKET , BY PRODUCT, 2020-2030 ($MILLION)
TABLE 13.U.S. VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 14.CANADA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 15.CANADA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 16.MEXICO VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 17.MEXICO VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20.EUROPE VASCULAR DISEASE DEVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 21.GERMANY VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 22.GERMANY VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23.FRANCE VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 24.FRANCE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.UK VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 26.UK VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 27.ITALY VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 28.ITALY VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 29.SPAIN VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 30.SPAIN VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.REST OF EUROPE VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 32.REST OF EUROPE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33.EUROPE VASCULAR DISEASE DEVICES MARKET , BY PRODUCT, 2020-2030 ($MILLION)
TABLE 34.EUROPE VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 35.ASIA-PACIFIC VASCULAR DISEASES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 36.CHINA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 37.CHINA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.JAPAN VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 39.JAPAN VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 40.INDIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 41.INDIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42.AUSTRALIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 43.AUSTRALIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.SOUTH KOREA VASCULAR DISEASES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 45.SOUTH KOREA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 46.REST OF ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 47.REST OF ASIA PACIFIC VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48.ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 49.ASIA-PACIFIC VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.LAMEA VASCULAR DISEASES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 51.BRAZIL VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 52.BRAZIL VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.SAUDI ARABIA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 54.SAUDI ARABIA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55.SOUTH AFRICA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 56.SOUTH AFRICA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 57.REST OF LAMEA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 58.REST OF LAMEA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 59.LAMEA VASCULAR DISEASE DEVICES MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 60.LAMEA VASCULAR DISEASE DEVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61.PHILIPS: COMPANY SNAPSHOT
TABLE 62.PHILIPS: OPERATING SEGMENTS
TABLE 63.PHILIPS: PRODUCT PORTFOLIO
TABLE 64.MEDTRONIC: COMPANY SNAPSHOT
TABLE 65.MEDTRONIC: OPERATING SEGMENT
TABLE 66.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 67.ABBOTT: COMPANY SNAPSHOT
TABLE 68.ABBOTT: OPERATING SEGMENT
TABLE 69.ABBOTT: PRODUCT PORTFOLIO
TABLE 70.ABBOTT.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 71.BOSTON: COMPANY SNAPSHOT
TABLE 72.BOSTON: OPERATING SEGMENT
TABLE 73.BOSTON: PRODUCT PORTFOLIO
TABLE 74.BOSTON.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 75.BD: COMPANY SNAPSHOT
TABLE 76.BD: OPERATING SEGMENT
TABLE 77.BD: PRODUCT PORTFOLIO
TABLE 78.TERUMO: COMPANY SNAPSHOT
TABLE 79.TERUMO: OPERATING SEGMENT
TABLE 80.TERUMO: PRODUCT PORTFOLIO
TABLE 81.TERUMO.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 82.CORDIS: COMPANY SNAPSHOT
TABLE 83.CORDIS: OPERATING SEGMENT
TABLE 84.CORDIS: PRODUCT PORTFOLIO
TABLE 85.B. BRAUN: COMPANY SNAPSHOT
TABLE 86.B. BRAUN: OPERATING SEGMENT
TABLE 87.B. BRAUN: PRODUCT PORTFOLIO
TABLE 88.IVASCULAR: COMPANY SNAPSHOT
TABLE 89.IVASCULAR: OPERATING SEGMENT
TABLE 90.IVASCULAR: PRODUCT PORTFOLIO
TABLE 91.IVASCULAR.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92.MERIT: COMPANY SNAPSHOT
TABLE 93.MERIT: OPERATING SEGMENT
TABLE 94.MERIT: PRODUCT PORTFOLIO
TABLE 95.MERIT.: KEY STRATEGIC MOVES AND DEVELOPMENTS

List of Figures

LIST OF FIGURES

FIGURE 01.VASCULAR DISEASE DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR STENTS BY COUNTRY, 2020 & 2030 (%)
FIGURE 14.VASCULAR DISEASE DEVICES MARKET DRUG-ELUTING STENTS, 2020 & 2030 ($MILLION)
FIGURE 15.VASCULAR DISEASE DEVICES MARKET BARE-METAL CORONARY STENTS, 2020 & 2030 ($MILLION)
FIGURE 16.VASCULAR DISEASE DEVICES MARKET BIOABSORBABLE STENTS, 2020 & 2030 ($MILLION)
FIGURE 17.VASCULAR DISEASE DEVICES MARKET ILIAC ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 18.VASCULAR DISEASE DEVICES MARKET FEMORAL ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 19.VASCULAR DISEASE DEVICES MARKET RENAL ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 20.VASCULAR DISEASE DEVICES MARKET CAROTID ARTERY STENTS, 2020 & 2030 ($MILLION)
FIGURE 21.VASCULAR DISEASE DEVICES MARKET SYNTHETIC GRAFTS, 2020 & 2030 ($MILLION)
FIGURE 22.VASCULAR DISEASE DEVICES MARKET VENA CAVA FILTERS, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR BALLOONS BY COUNTRY, 2020 & 2030 (%)
FIGURE 24.BARE/NORMAL BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 25.DRUG-COATED BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 26.SCORING BALLOON IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR CATHETERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 28.ANGIOGRAPHY IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 29.IVUS / OCT IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 30.GUIDING IN VASCULAR DISEASES MARKET, 2020 & 2030 ($MILLION)
FIGURE 31.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR PLAQUE MODIFICATION DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 32.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR HEMODYNAMIC FLOW ALTERATION DEVICES BY COUNTRY, 2020 & 2030 (%)
FIGURE 33.COMPARATIVE SHARE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR OTHERS BY COUNTRY, 2020 & 2030 (%)
FIGURE 34.COMPARATIVE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020–2030 (%)
FIGURE 35.COMPARATIVE ANALYSIS OF VASCULAR DISEASE DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 36.PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 39.MEDTRONIC: NET SALES, 2020 ($MILLION)
FIGURE 40.MEDTRONIC: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 41.MEDTRONIC: REVENUE SHARE BY REGION 2020(%)
FIGURE 42.ABBOTT: NET SALES, 2020 ($MILLION)
FIGURE 43.ABBOTT: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 44.ABBOTT: REVENUE SHARE BY REGION 2020(%)
FIGURE 45.BOSTON: NET SALES, 2020 ($MILLION)
FIGURE 46.BOSTON: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 47.BOSTON: REVENUE SHARE BY REGION 2020(%)
FIGURE 48.BD: NET SALES, 2020 ($MILLION)
FIGURE 49.BD: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 50.BD: REVENUE SHARE BY REGION 2020(%)
FIGURE 51.TERUMO: NET SALES, 2020 ($MILLION)
FIGURE 52.TERUMO: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 53.TERUMO: REVENUE SHARE BY REGION 2020(%)
FIGURE 54.CORDIS: NET SALES, 2020 ($MILLION)
FIGURE 55.CORDIS: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 56.CORDIS: REVENUE SHARE BY REGION 2020(%)
FIGURE 57.B. BRAUN: NET SALES, 2020 ($MILLION)
FIGURE 58.B. BRAUN: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 59.B. BRAUN: REVENUE SHARE BY REGION 2020(%)
FIGURE 60.MERIT: NET SALES, 2020 ($MILLION)
FIGURE 61.MERIT: REVENUE SHARE PER SEGMENT 2020(%)
FIGURE 62.MERIT: REVENUE SHARE BY REGION 2020(%)

ページTOPに戻る

Table of Contents

Summary

The global vascular disease devices market was valued at $26,522.24 million in 2020, and is projected to reach $ 51,802.14 million by 2030, registering a CAGR of 6.50% from 2021 to 2030.
The vascular diseases refer to any pathological condition that affects natural blood circulatory system, such as peripheral artery disease (PAD). The vascular diseases include stroke, peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), arteriovenous malformation (AVM), critical limb-threatening ischemia (CLTI), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins. The incidence of vascular diseases has increased significantly over the last few years. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019. Vascular diseases may be caused due to high blood pressure, cholesterol deposition, injury, genetics, and infections. Diabetes, hypertension, obesity, alcohol consumption, and tobacco smoking are the risk factors for vascular diseases.
Specially designed devices such as balloons, stents, catheters, and filters are used to perform various vascular surgeries. The artery stent is a small, metal mesh tube that expands inside a coronary artery. A stent is often placed during or immediately after angioplasty. It helps prevent the artery from closing up again. Similarly, at the blockage, the balloon is inflated and the spring-like stent expands and locks into place inside the artery. The stent stays in the artery permanently to hold it open and improve blood flow to the heart. In addition, cardiac catheter is a very small, flexible, hollow tube put into a blood vessel in the groin, arm, or neck. Then surgeon threads it through the blood vessel into the aorta and the heart. The cardiac catheterization is used to diagnose and evaluate common heart and blood vessel problems such as chest pain or an abnormal stress test due to coronary artery disease, heart valve conditions like a leaky or narrowed valve, a high blood pressure condition in the lungs, or blood clots.
Increase in prevalence of vascular diseases worldwide, drive the growth of the vascular disease devices market. For instance, according to a report by the American Heart Association, in 2019, 197.2 million people were living with ischemic heart disease (IHD). In addition, increase in diabetes and hypertension propels the growth of the vascular disease devices market. According to the World Health Organization (WHO) in 2021, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension. The older people are more susceptible to vascular disease. Thus, rise in the geriatric population further contributed in the growth of vascular disease devices market. However, product recalls and failures may limit the growth of the market.
The vascular disease devices market is segmented on the basis of product, end-user and region. By product, the market is divided into stents, balloons, catheters, plaque modification devices, hemodynamic flow alteration devices, and others. The stents are further classified into coronary stents, peripheral stents, and stents-related products. The coronary stents are divided into drug-eluting stents bare-metal coronary stents and bioabsorbable stents. The peripheral stents are further classified as iliac, femoral-popliteal, renal, and carotid. The stents-related products are classified as synthetic grafts and vena cava filters.
The balloons are further divided into bare/normal balloons, drug-coated balloons, and scoring balloons. The catheters are classified as angiography, IVUS/OCT, and guiding.
By end-user, the market is divided into hospitals & cardiac centers and ambulatory surgical centers. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, Cordis, B. Braun Melsungen Ag, Ivascular, Merit Medical, and Koninklijke Philips N.V.

KEY BENEFITS FOR STAKEHOLDERS

 The report provides an in-depth analysis of the global vascular disease devices market size along with the current trends and future estimations to elucidate the imminent investment pockets.
 It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
 A comprehensive analysis of the region assists to understand the regional market and facilitate strategic business planning and determine prevailing opportunities.
 The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global vascular disease devices market growth.

KEY MARKET SEGMENTS
#By Product
## Stents
### Coronary Stents
#### Drug-eluting Stents
####Bare-metal Coronary
####Stents Bioabsorbable Stents

###Peripheral Stents
####Iliac
####Femoral-Popliteal
####Renal
####Carotid

###Stent Related Implant
####Synthetic Grafts
####Vena Cava Filters

##Balloons
###Bare/Normal balloon
###Drug coated balloons
###Scoring balloons

##Catheters
###Angiography
###IVUS/OCT
###Guiding

##Plaque Modification Devices
##Hemodynamic Flow Alteration Devices
##Others
#By End User
##Hospitals and Cardiac Centers
##Ambulatory Surgical Centers

#By Region
##North America
###U.S.
###Canada
###Mexico

##Europe
###Germany
###France
###UK
###Italy
###Spain
###Rest of Europe

##Asia Pacific
###Japan
###China
###Australia
###India
###South Korea
###Rest of Asia Pacific

##LAMEA
###Brazil
###Saudi Arabia
###South Africa
###Rest of LAMEA

KEY MARKET PLAYERS
 Medtronic,
 Boston scientific corporation,
 Abbott laboratories,
 Becton Dickinson and company,
 Terumo Corporation,
 Cordis,
 B. Braun Melsungen AG,
 Ivascular,
 Merit Medical,
 Koninklijke Philips N.V.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（電子カルテ、HER）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（ambulatory）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（電子カルテ、HER）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（ambulatory）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?